Canadian medical cannabis producer hit with class-action suit

Canadian medical marijuana producer Organigram, having already replaced its CEO,┬ánow is the subject of a class-action lawsuit┬áinvolving pesticide-contaminated cannabis. A Halifax-based law firm alleged in its Friday filing that the lead plaintiff consumed Organigram’s MMJ products for almost a year before learning the cannabis could be contaminated with potentially toxic pesticides, the Montreal Gazette reported. The firm also said in its suit that upwards of 2,000 Canadians may have purchased medical marijuana products containing either myclobutanil or bifenazate, pesticides that are not approved for use on cannabis. Myclobutanil in particular is controversial throughout the cannabis industry. ... Canadian medical cannabis producer hit with class-action suit is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs